This is supported by the Effect of Strict Blood Pressure Control and ACE Inhibition on the Progression of CKD in Pediatric Patients (ESCAPE) trial (385 participants), which demonstrated lower CKD progression with intensive BP control, particularly in proteinuric kidney disease.144. The gene discussed is ACE; the disease is chronic kidney disease.